Risk factors for presumptive melanoma in skin cancer screening: American Academy of Dermatology National Melanoma/Skin Cancer Screening Program experience 2001-2005

Journal of the American Academy of Dermatology

Volumn 57, Issue 1, 2007, Pages 60-66

  Goldberg, Matthew S ^c   Doucette, John T ^a   Lim, Henry W ^d   Spencer, James ^b   Carucci, John A ^e   Rigel, Darrell S ^f  

^a Departments of Community and Preventive Medicine

^b Dermatology   (Switzerland)

^c MOUNT SINAI SCHOOL OF MEDICINE   (United States)

^d HENRY FORD HOSPITAL   (United States)

^e WEILL CORNELL MEDICAL COLLEGE   (United States)

^f NEW YORK UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; CANCER CENTER; CANCER DIAGNOSIS; CANCER SCREENING; CONFIDENCE INTERVAL; CONTROLLED STUDY; FEMALE; HEALTH PROGRAM; HUMAN; MAJOR CLINICAL STUDY; MALE; MASS SCREENING; PHENOTYPE; POPULATION; PRIORITY JOURNAL; RISK FACTOR; SKIN CANCER; SKIN CARE; SKIN EXAMINATION; STATISTICAL ANALYSIS; UNITED STATES;

ADULT; AGED; AGED, 80 AND OVER; DERMATOLOGY; HEALTH PROMOTION; HUMANS; MASS SCREENING; MELANOMA; MIDDLE AGED; PHYSICAL EXAMINATION; REGRESSION ANALYSIS; RISK FACTORS; SKIN NEOPLASMS;

EID: 34250369657     PISSN: 01909622     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jaad.2007.02.010     Document Type: Article

References (53)

1. Bevona C., and Sober A.J. Melanoma incidence trends. Dermatol Clin 20 (2002) 589-595
2. Jemal A., Siegel R., Ward E., Murray T., Xu J., Smigal C., et al. Cancer statistics, 2006. CA Cancer J Clin 56 (2006) 106-130
3. Jemal A., Devesa S.S., Hartge P., and Tucker M.A. Recent trends in cutaneous melanoma incidence among whites in the United States. J Natl Cancer Inst 93 (2001) 678-683
4. Bickers D.R., Lim H.W., Margolis D., Weinstock M.A., Goodman C., Faulkner E., et al. The burden of skin diseases: 2004. A joint project of the American Academy of Dermatology Association and the Society for Investigative Dermatology. J Am Acad Dermatol 55 (2006) 490-500
5. Geller A.C., Miller D.R., Annas G.D., Demierre M.F., Gilchrest B.A., and Koh H.K. Melanoma incidence and mortality among US whites, 1969-1999. JAMA 288 (2002) 1719-1720
6. Geller A.C., Miller D.R., Lew R.A., Clapp R.W., Wenneker M.B., and Koh H.K. Cutaneous melanoma mortality among the socioeconomically disadvantaged in Massachusetts. Am J Public Health 86 (1996) 538-544
7. American Academy of Dermatology. Help set a Guinness World Record by getting a free skin cancer screening. Available at: http://www.aad.org/public/News/NewsReleases/Press+Release+Archives/Skin+ Cancer+and+Sun+Safety/Help+Set+a+Guinness+World+Record+by+Getting+a+Free +Skin+Cancer+Screening.htm. Accessed May 1, 2006.
8. Robinson J.K., Rigel D.S., and Amonette R.A. What promotes skin self-examination?. J Am Acad Dermatol 38 5 pt 1 (1998) 752-757
9. Koh H.K. Cutaneous melanoma. N Engl J Med 325 (1991) 171-182
10. Koh H.K., Geller A.C., Miller D.R., and Lew R.A. Early detection of melanoma: an ounce of prevention may be a ton of work. J Am Acad Dermatol 28 (1993) 645-647
11. Koh H.K., Norton L.A., Geller A.C., Sun T., Rigel D.S., Miller D.R., et al. Evaluation of the American Academy of Dermatology's national skin cancer early detection and screening program. J Am Acad Dermatol 34 (1996) 971-978
12. Aitken J.F., Janda M., Elwood M., Youl P.H., Ring I.T., and Lowe J.B. Clinical outcomes from skin screening clinics within a community-based melanoma screening program. J Am Acad Dermatol 54 (2006) 105-114
13. Marks R. Positive predictive value of skin cancer screening. J Am Acad Dermatol 55 (2006) 544-545
14. Jonna B.P., Delfino R.J., Newman W.G., and Tope W.D. Positive predictive value for presumptive diagnoses of skin cancer and compliance with follow-up among patients attending a community screening program. Prev Med 27 (1998) 611-616
15. Swetter S.M., Waddell B.L., Vazquez M.D., and Khosravi V.S. Increased effectiveness of targeted skin cancer screening in the Veterans Affairs population of Northern California. Prev Med 36 (2003) 164-171
16. Williams H.A., Fritschi L., Beauchamp C., and Katris P. Evaluating the usefulness of self-reported risk factors in a skin cancer screening program. Melanoma Res 16 (2006) 341-345
17. Demierre M.F. Thin melanomas and regression, thick melanomas and older men: prognostic implications and perspectives on secondary prevention. Arch Dermatol 138 (2002) 678-682
18. Geller A.C., Zhang Z., Sober A.J., Halpern A.C., Weinstock M.A., Daniels S., et al. The first 15 years of the American Academy of Dermatology skin cancer screening programs: 1985-1999. J Am Acad Dermatol 48 (2003) 34-41
19. Koh H., Caruso A., Gage I., Geller A.C., Prout M.N., White H., et al. Evaluation of melanoma/skin cancer screening in Massachusetts. Preliminary results. Cancer 65 (1990) 375-379
20. Freedberg K.A., Geller A.C., Miller D.R., Lew R.A., and Koh H.K. Screening for malignant melanoma: a cost-effectiveness analysis. J Am Acad Dermatol 41 5 pt 1 (1999) 738-745
21. Snels D.G., Hille E.T., Gruis N.A., and Bergman W. Risk of cutaneous malignant melanoma in patients with nonfamilial atypical nevi from a pigmented lesions clinic. J Am Acad Dermatol 40 5 pt 1 (1999) 686-693
22. Kirkpatrick C.S., Lee J.A.H., and White E. Melanoma risk by age and socio-economic status. Int J Cancer 46 (1990) 1-4
23. Evans R.D., Kopf A.W., Lew R.A., Rigel D.S., Bart R.S., Friedman R.J., et al. Risk factors for the development of malignant melanoma. I. Review of case-control studies. J Dermatol Surg Oncol 14 (1988) 393-408
24. Slade J., Marghoob A.A., Salopek T.G., Rigel D.S., Kopf A.W., and Bart R.S. Atypical mole syndrome: risk factor for cutaneous malignant melanoma and implications for management. J Am Acad Dermatol 32 (1995) 479-494
25. Weinstock M.A. Progress and prospects on melanoma: the way forward for early detection and reduced mortality. Clin Cancer Res 12 7 pt 2 (2006) 2297S-300S
26. Janda M., Lowe J.B., Elwood M., Ring I.T., Youl P.H., and Aitken J.F. Do centralised skin screening clinics increase participation in melanoma screening (Australia)?. Cancer Causes Control 17 (2006) 161-168
27. Hersey P., Sillar R.W., Howe C.G., Burton R.C., Darbar S.V., Foster H.M., et al. Factors related to the presentation of patients with thick primary melanomas. Med J Aust 154 (1991) 583-587
28. Koh H.K., Geller A.C., Miller D.R., Caruso A., Gage I., and Lew R.A. Who is being screened for melanoma/skin cancer? Characteristics of persons screened in Massachusetts. J Am Acad Dermatol 24 (1991) 271-277
29. Fisher N.M., Schaffer J.V., Berwick M., and Bolognia J.L. Breslow depth of cutaneous melanoma: impact of factors related to surveillance of the skin, including prior skin biopsies and family history of melanoma. J Am Acad Dermatol 53 (2005) 393-406
30. Azzarello L.M., and Jacobsen P.B. Factors influencing participation in cutaneous screening among individuals with a family history of melanoma. J Am Acad Dermatol 56 (2007) 398-406
31. Geller A.C., Sober A.J., Zhang Z., Brooks D.R., Miller D.R., Halpern A., et al. Strategies for improving melanoma education and screening for men age ≥50 years: findings from the American Academy of Dermatology National Skin Cancer Screening Program. Cancer 95 (2002) 1554-1561
32. Janda M., Youl P.H., Lowe J.B., Baade P.D., Elwood M., Ring I.T., et al. What motivates men age ≥50 years to participate in a screening program for melanoma?. Cancer 107 (2006) 815-873
33. McPherson M., Elwood M., English D.R., Baade P.D., Youl P.H., and Aitken J.F. Presentation and detection of invasive melanoma in a high-risk population. J Am Acad Dermatol 54 (2006) 783-792
34. Rigel D.S. Identification of those at highest risk for development of malignant melanoma. Adv Dermatol 10 (1995) 151-170
35. Rigel D.S., and Carucci J.A. Malignant melanoma: prevention, early detection, and treatment in the 21st century. CA Cancer J Clin 50 (2000) 215-236
36. Geller A.C., Miller D.R., Swetter S.M., Demierre M.F., and Gilchrest B.A. A call for the development and implementation of a targeted national melanoma screening program. Arch Dermatol 142 (2006) 504-507
37. Weinstock M.A. Cutaneous melanoma: public health approach to early detection. Dermatol Ther 19 (2006) 26-31
38. Rhodes A.R. Cutaneous melanoma and intervention strategies to reduce tumor-related mortality: what we know, what we don't know, and what we think we know that isn't so. Dermatol Ther 19 (2006) 50-69
39. Cho E., Rosner B.A., Feskanich D., and Colditz G.A. Risk factors and individual probabilities of melanoma for whites. J Clin Oncol 23 (2005) 2669-2675
40. Nijsten T., Leys C., Verbruggen K., Verlinden V., Drieghe J., Stas M., et al. Case-control study to identify melanoma risk factors in the Belgian population: the significance of clinical examination. J Eur Acad Dermatol Venereol 19 (2005) 332-339
41. Rigel D.S., Friedman R.J., Kopf A.W., Weltman R., Prioleau P.G., Safai B., et al. Importance of complete cutaneous examination for the detection of malignant melanoma. J Am Acad Dermatol 14 5 pt 1 (1986) 857-860
42. Hall H.I., Miller D.R., Rogers J.D., and Bewerse B. Update on the incidence and mortality from melanoma in the United States. J Am Acad Dermatol 40 (1999) 35-42
43. Campbell M., and Swinscow T.D.V. Statistics at square one (9th ed) (1997), BMJ Publishing Group, London
44. Epstein D.S., Lange J.R., Gruber S.B., Mofid M., and Koch S.E. Is physician detection associated with thinner melanomas?. JAMA 281 (1999) 640-643
45. Chen S.C., Pennie M.L., Kolm P., Warshaw E.M., Weisberg E.L., Brown K.M., et al. Diagnosing and managing cutaneous pigmented lesions: primary care physicians versus dermatologists. J Gen Intern Med 21 (2006) 678-682
46. McKenna D.B., Marioni J.C., Lee R.J., Prescott R.J., and Doherty V.R. A comparison of dermatologists', surgeons' and general practitioners' surgical management of cutaneous melanoma. Br J Dermatol 151 (2004) 636-644
47. Lim H.W., Gilchrest B.A., Cooper K.D., Bischoff-Ferrari H.A., Rigel D.S., Cyr W.H., et al. Sunlight, tanning booths, and vitamin D. J Am Acad Dermatol 52 (2005) 868-876
48. Chen Y.T., Dubrow R., Zheng T., Barnhill R.L., Fine J., and Berwick M. Sunlamp use and the risk of cutaneous malignant melanoma: a population-based case-control study in Connecticut, USA. Int J Epidemiol 27 (1998) 758-765
49. Buckel T.B., Goldstein A.M., Fraser M.C., Rogers B., and Tucker M.A. Recent tanning bed use: a risk factor for melanoma. Arch Dermatol 142 (2006) 485-488
50. Helfand M., Mahon S.M., Eden K.B., Frame P.S., and Orleans C.T. Screening for skin cancer. Am J Prev Med 20 3 suppl (2001) 47-58
51. U.S. Preventive Services Task Force. Counseling to prevent skin cancer: recommendations and rationale of the U.S. Preventive Services Task Force. MMWR Recomm Rep 52 RR-15 (2003) 13-17
52. Berg A.O. Counseling to prevent skin cancer: recommendations and rationale. Am J Nurs 104 (2004) 87-90
53. US Preventive Services Task Force: Berg A.O., Allan J.D., Frame P.S., Homer C.J., Lieu T.A., Mulrow C.D., et al. Screening for skin cancer: recommendations and rationale. Am J Nurs 102 (2002) 97-101